Thu, March 17, 2011
[ Thu, Mar 17th 2011 ] - Market Wire
Alnylam Responds to Tekmira Complaint
[ Thu, Mar 17th 2011 ] - Market Wire
AngioDynamics to Report Fiscal 2011 Third Quarter .. Results and Hold Conference Call on April 5, 2011
Wed, March 16, 2011
[ Wed, Mar 16th 2011 ] - Market Wire
CEO da Covidien deixar o cargo em 1 de julho. Seu Sucessor j foi Nomeado
[ Wed, Mar 16th 2011 ] - Market Wire
El 1 de julio se retira el CEO de Covidien; ya se ha nombrado el sucesor
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien elige como presidente y director ejecutivo a Jose E. Almeida
[ Wed, Mar 16th 2011 ] - Market Wire
St. Jude Medical Celebrates Two Millionth Mechanical Heart Valve Implant
[ Wed, Mar 16th 2011 ] - Market Wire
PATIENT HOME MONITORING ANNOUNCES NEW CHIEF FINANCIAL AND OPERATIONS OFFICER
[ Wed, Mar 16th 2011 ] - Market Wire
Study Shows SANUWAVEa?s Dermapace is Significantl .. ric Oxygen Therapy in Healing Chronic Diabetic Fo
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien Elects Jose E. Almeida President and Chief Executive Officer
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien CEO to Retire July 1; Successor Named
[ Wed, Mar 16th 2011 ] - Market Wire
Le PDG de Covidien partira la retraite le 1er juillet, son successeur a ©t© d©sign©
[ Wed, Mar 16th 2011 ] - Market Wire
Covidiens CEO scheidet am 1. Juli aus dem Amt; Nachfolger ernannt
[ Wed, Mar 16th 2011 ] - Market Wire
CEO di Covidien in pensione dal 1 luglio - nominato successore
[ Wed, Mar 16th 2011 ] - Market Wire
Covidien sceglie Jose E. Almeida come Presidente e CEO
[ Wed, Mar 16th 2011 ] - Market Wire
TSO3 DISCLOSES FOURTH QUARTER AND FULL YEAR 2010 .. SCAL RESULTS AND UPDATES ON SUBSEQUENT ACTIVITIES
[ Wed, Mar 16th 2011 ] - Market Wire
Amedisys Presents Home Care and Hospice Face-to-Face Requirements Webinar to Health Care Leaders
[ Wed, Mar 16th 2011 ] - Market Wire
AlphaRx Provides Corporate and Development Update
Tue, March 15, 2011
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien bepaalt contant kwartaaldividend en maak .. n van jaarlijkse algemene vergadering 2011 bekend
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien Declares Quarterly Cash Dividend and Announces Results from 2011 Annual General Meeting
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien setzt vierteljhrliche Bardividende fest .. ibt Ergebnisse der Jahresversammlung 2011 bekannt
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien declara dividendo en efectivo trimestral y anuncia resultados de la asamblea general 2011
[ Tue, Mar 15th 2011 ] - Market Wire
Covidien d©clare un dividende trimestriel en esp .. les r©sultats de son assembl©e g©n©rale 2011
[ Tue, Mar 15th 2011 ] - Market Wire
Exelixis Announces Exercise in Full of Option to .. es and Closing of Public Offering of Common Stock
[ Tue, Mar 15th 2011 ] - Market Wire
Concentra Successfully Deploys ZeOmegaa?s Integrated Workflow Solution
[ Tue, Mar 15th 2011 ] - Market Wire
Seattle Genetics and Millennium Expand Antibody-Drug Conjugate Collaboration
[ Tue, Mar 15th 2011 ] - Market Wire
Biomagnetics Begins Miniaturization Process for Biosensor a" Major Step Toward Commercialization
[ Tue, Mar 15th 2011 ] - Market Wire
Progenics Pharmaceuticals Announces Fourth Quarter and Year-End 2010 Financial Results
[ Tue, Mar 15th 2011 ] - Market Wire
Unigene Doses First Patient in Phase 2 Oral PTH S .. Treatment of Osteoporosis in Postmenopausal Women
[ Tue, Mar 15th 2011 ] - Market Wire
Alnylam Pharmaceuticals Reaches Settlement in Litigation Regarding Tuschl Patents
[ Tue, Mar 15th 2011 ] - Market Wire
Merck to Present at Barclays Capital 2011 Global Healthcare Conference
[ Tue, Mar 15th 2011 ] - Market Wire
Pro-Pharmaceuticals Reports Full Year and Fourth Quarter 2010 Financial Results
[ Tue, Mar 15th 2011 ] - Market Wire
Illumina Prices $800 Million Convertible Senior Notes
Mon, March 14, 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Incytea?s Ruxolitinib (INCB18424) Meets Primary Endpoint in Second Phase III Study
[ Mon, Mar 14th 2011 ] - Market Wire
Illumina to Offer $800 Million Convertible Senior Notes
[ Mon, Mar 14th 2011 ] - Market Wire
Teva to Present at the Barclays Capital 2011 Global Healthcare Conference
[ Mon, Mar 14th 2011 ] - Market Wire
Health Net, Inc. Investigating Unaccounted-for Server Drives
[ Mon, Mar 14th 2011 ] - Market Wire
30 AM E.T.
[ Mon, Mar 14th 2011 ] - Market Wire
Repligen Reports Positive Phase 3 Clinical Trial Results for RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ] - Market Wire
Bristol-Myers Squibb Awards Grant to the American .. tion to Address U.S. HIV Medical Workforce Shorta
[ Mon, Mar 14th 2011 ] - Market Wire
HemaCare Reports Fourth Quarter and Year End Results
[ Mon, Mar 14th 2011 ] - Market Wire
Medtronic Announces Global Launch of New Heart Va .. Ring Designed to Adapt to Hearta?s Natural Valve
[ Mon, Mar 14th 2011 ] - Market Wire
Thermo Fisher Scientific Extends Legacy of Innovation at Pittcon 2011
[ Mon, Mar 14th 2011 ] - Market Wire
GTSO Eyes April for First Shipment of Mongolian Rare Earth Ore
[ Mon, Mar 14th 2011 ] - Market Wire
Anacor Pharmaceuticals Completes Enrollment in Phase 2b Trial of AN2728 for Psoriasis
[ Mon, Mar 14th 2011 ] - Market Wire
Repligen Announces Conference Call to Discuss Pha .. cal Trial Results of RG1068 in Pancreatic Imaging
[ Mon, Mar 14th 2011 ] - Market Wire
Covidien Announces New Data on Hernia and Abdomin .. ir Products to Be Presented at Hernia Repair 2011
[ Mon, Mar 14th 2011 ] - Market Wire
Human Genome Sciences Appoints George Morrow to its Board of Directors
Sun, March 13, 2011
[ Sun, Mar 13th 2011 ] - Market Wire
DaVita Enhances Already Strong Governance Policies
Sat, March 12, 2011
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead raccomanda di rifiutare la?offerta di minigara presentata da TRC Capital Corporation
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead empfiehlt Ablehnung von Mini-bernahmeangebot durch TRC Capital Corporation
[ Sat, Mar 12th 2011 ] - Market Wire
Gilead Adviseert Afwijzing van Mini-Overnamebod door TRC Capital Corporation
Fri, March 11, 2011
[ Fri, Mar 11th 2011 ] - Market Wire
The Rosen Law Firm Files Class Action Lawsuit Cha .. ceuticals Corporation With Securities Fraud - RPC
[ Fri, Mar 11th 2011 ] - Market Wire
Edwards Lifesciences Acquires Embrella Cardiovascular, Inc.
[ Fri, Mar 11th 2011 ] - Market Wire
Focus and SOQUEM confirm historical REE-Cu-Fe gra .. 52% TREO, 0.15% Cu, 3.70% P2O5 and 49.9% Fe2O3 at
[ Fri, Mar 11th 2011 ] - Market Wire
Aetna Recognized by the National Business Group on Health for Reducing Disparities in Care
[ Fri, Mar 11th 2011 ] - Market Wire
Orthofix Sports Medicine Launches Three New Products in March
[ Fri, Mar 11th 2011 ] - Market Wire
Obagi Medical Products to Present at the 23rd Annual Roth OC Growth Stock Conference
[ Fri, Mar 11th 2011 ] - Market Wire
NovaDel Pharma Inc. to Present at ROTH 23rd Annual OC Growth Stock Conference
[ Fri, Mar 11th 2011 ] - Market Wire
GTSO President to Participate in Rare Earths Briefing Today at U.S. Capitol
[ Fri, Mar 11th 2011 ] - Market Wire
Human Genome Sciences oraz GlaxoSmithKline oglasz .. DA na wprowadzenie na rynek BENLYSTA® (Belimumab
[ Fri, Mar 11th 2011 ] - Market Wire
Equity Research on Elan Corp. plc and Valeant Pha .. Drug Delivery Sector Sees Opportunities and Growi
[ Fri, Mar 11th 2011 ] - Market Wire
CytRx Reports 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Synta Announces Clinical Program Updates and 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Human Genome Sciences????????????BENLYSTA® (?????) ?FDA??????????????
[ Fri, Mar 11th 2011 ] - Market Wire
Centric Health Reports Solid 2010 Financial Results
[ Fri, Mar 11th 2011 ] - Market Wire
Covidien????????????????FDA??
Thu, March 10, 2011
[ Thu, Mar 10th 2011 ] - Market Wire
Covidien recibe la autorizacin de la FDA para los .. basados en uranio de bajo enriquecimiento produci
[ Thu, Mar 10th 2011 ] - Market Wire
Covidien obtient la?approbation de la FDA pour un .. rique du Sud bas© sur de la?uranium faiblement e
[ Thu, Mar 10th 2011 ] - Market Wire
A Brighter Decade Ahead for Biotech - In-Depth Re .. ch Featuring Biodel Inc. and MannKind Corporation
[ Thu, Mar 10th 2011 ] - Market Wire
Anacor Pharmaceuticals Reports 2010 Fourth Quarter and Year End Financial Results
[ Thu, Mar 10th 2011 ] - Market Wire
Exenatide Once Monthly Showed Positive Results in Phase 2 Study
[ Thu, Mar 10th 2011 ] - Market Wire
CompCare Expands Management Team to Drive Continued Innovation and Bottom-Line Growth
[ Thu, Mar 10th 2011 ] - Market Wire
Northstar Healthcare Reports 2010 Results
[ Thu, Mar 10th 2011 ] - Market Wire
Given Imaging Receives FDA Clearance for Expanded PillCam(R) SB Indications
[ Thu, Mar 10th 2011 ] - Market Wire
Teleflex Announces FDA Clearance to Market Arrow .. tStep Antegrade Catheter for Chronic Hemodialysis
[ Thu, Mar 10th 2011 ] - Market Wire
Columbia Laboratories Reports Fourth Quarter and Year End 2010 Financial Results
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences e GlaxoSmithKline annuncian .. zione da parte dell'FDA per il BENLYSTA® (belimu
[ Thu, Mar 10th 2011 ] - Market Wire
Santarus Initiates Phase I Clinical Study with SAN-300
[ Thu, Mar 10th 2011 ] - Market Wire
BioSante Pharmaceuticals Closes $25.1 Million Registered Direct Offering
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences und GlaxoSmithKline melden .. (Belimumab) zur Behandlung von systemischem Lupus
[ Thu, Mar 10th 2011 ] - Market Wire
Human Genome Sciences et GlaxoSmithKline annoncen .. ur BENLYSTA® (Belimumab) dans le traitement du l
Wed, March 9, 2011
[ Wed, Mar 09th 2011 ] - Market Wire
The Law Offices of Vincent Wong Announce an Inves .. hes of Fiduciary Duty by the Board of TomoTherapy
[ Wed, Mar 09th 2011 ] - Market Wire
A.M. Best Revises Outlook to Stable for Coventry Health Care, Inc. and Its Subsidiaries
[ Wed, Mar 09th 2011 ] - Market Wire
Renegade Petroleum Ltd. Announces Closing of $41.9 Million Bought Deal Financing
[ Wed, Mar 09th 2011 ] - Market Wire
Lpath Granted Another Key U.S. Patent Related to iSONEP and ASONEP Drug Programs
[ Wed, Mar 09th 2011 ] - Market Wire
Fight Colorectal Cancer and Genomic Health Launch Unique Online Resource for Colon Cancer Patients
[ Wed, Mar 09th 2011 ] - Market Wire
Avid Bioservices to Present Comparability Studies .. ge-Scale Manufacturing of Clinical-Stage Antibody
[ Wed, Mar 09th 2011 ] - Market Wire
Medivation Announces Fourth Quarter and Year-End .. ults Teleconference and Webcast on March, 16 2011
[ Wed, Mar 09th 2011 ] - Market Wire
Corcept Therapeutics Announces Fourth Quarter Results and Corporate and Development Update
[ Wed, Mar 09th 2011 ] - Market Wire
Biotech's Response to the MRSA Epidemic
[ Wed, Mar 09th 2011 ] - Market Wire
Synergy Pharmaceuticals verzorgt presentatie tijdens de BIO-Europe Spring 2011-conferentie
[ Wed, Mar 09th 2011 ] - Market Wire
DUSA Pharmaceuticals to Present at Roth Capital Partners 23rd Annual OC Growth Stock Conference
[ Wed, Mar 09th 2011 ] - Market Wire
Opexa Therapeutics Reports Year End 2010 Financial Results and Provides Corporate Update
[ Wed, Mar 09th 2011 ] - Market Wire
Biomagnetics to Receive Funding From BIOTECH Deve .. pment Partners for Commercialization of Biosensor
[ Wed, Mar 09th 2011 ] - Market Wire
Hythiam to Present at the Roth 23rd Annual OC Growth Stock Conference
[ Wed, Mar 09th 2011 ] - Market Wire
Lilly CEO Calls for Biopharmaceutical Industry Ch .. es and Policies That Encourage Medical Innovation
Tue, March 8, 2011
[ Tue, Mar 08th 2011 ] - Market Wire
Medtronic CareLink® Network Remote Monitoring He .. Improve Patient Care and Reduce Healthcare Costs
[ Tue, Mar 08th 2011 ] - Market Wire
Derma Sciences to Present at the Roth Capital Partners Growth Stock Conference
[ Tue, Mar 08th 2011 ] - Market Wire
China Kanghui Holdings Announces Participation in Upcoming Investor Events
[ Tue, Mar 08th 2011 ] - Market Wire
Exelixis Announces Proposed Public Offering of Common Stock
[ Tue, Mar 08th 2011 ] - Market Wire
Synergy Pharmaceuticals to Present at BIO-Europe Spring 2011 Conference
[ Tue, Mar 08th 2011 ] - Market Wire
Arrowhead Research to Present at the Roth Capital .. 3rd Annual OC Growth Stock Conference on March 16
[ Tue, Mar 08th 2011 ] - Market Wire
ZIOPHARM to Present at Barclays Capital 2011 Global Healthcare Conference
[ Tue, Mar 08th 2011 ] - Market Wire
Yellowhead Mining Reports Positive Results of Preliminary Economic Assessment
[ Tue, Mar 08th 2011 ] - Market Wire
Marina Biotech, Inc. to Present at the ROTH 23rd Annual OC Growth Stock Conference
[ Tue, Mar 08th 2011 ] - Market Wire
Dynavax Reports Fourth Quarter and Year End 2010 Financial Results
[ Tue, Mar 08th 2011 ] - Market Wire
Applied DNA Sciences, Inc. Migrates to the OTCQB Tier of the OTC Marketplace
[ Tue, Mar 08th 2011 ] - Market Wire
Cytori Patents Method of Making Stem and Regenerative Cell-Enriched Fat Grafts
[ Tue, Mar 08th 2011 ] - Market Wire
Peregrine Announces Initiation of Lung Cancer Investigator-Sponsored Trial
[ Tue, Mar 08th 2011 ] - Market Wire
GTSO JV Secures NewRare Earth Mining Lease in Mongolia
[ Tue, Mar 08th 2011 ] - Market Wire
Healthways Announces Planned Transition of President, Stefen Brueckner, to Senior Advisor Role
Mon, March 7, 2011
[ Mon, Mar 07th 2011 ] - Market Wire
Law Offices of Howard G. Smith Announces Investig .. rs of TomoTherapy Incorporated, in Connection wit
[ Mon, Mar 07th 2011 ] - Market Wire
The Law Office of Abe Shainberg Launches an Inves .. hes of Fiduciary Duty by the Board of TomoTherapy
[ Mon, Mar 07th 2011 ] - Market Wire
Prana to Present at Cowen and Company Health Care Conference
[ Mon, Mar 07th 2011 ] - Market Wire
Charles River to Present at March Conferences
[ Mon, Mar 07th 2011 ] - Market Wire
TomoTherapy Incorporated Shareholder Investigatio .. m Concerning Sale to Accuray Incorporated a" TOMO
[ Mon, Mar 07th 2011 ] - Market Wire
Murray, Frank & Sailer LLP Investigates Breaches .. cquisition Of TomoTherapy Incorporated By Accuray
[ Mon, Mar 07th 2011 ] - Market Wire
Kendall Law Group Investigates TomoTherapy Inc. Acquisition for Shareholders
[ Mon, Mar 07th 2011 ] - Market Wire
Rigrodsky & Long, P.A. Investigates Buyout of TomoTherapy Incorporated - TOMO
[ Mon, Mar 07th 2011 ] - Market Wire
Stellar's Common Shares Now Trading on OTCQB
[ Mon, Mar 07th 2011 ] - Market Wire
Daxor Announces Publication of Research Article D .. 100 Data to Guide Shock Resuscitation Led to Sign
[ Mon, Mar 07th 2011 ] - Market Wire
Allied Healthcare International Inc. Acquires ScotHomecare
[ Mon, Mar 07th 2011 ] - Market Wire
Amedisys to Present at the Raymond James and Asso .. es 32nd Annual Institutional Investors Conference
[ Mon, Mar 07th 2011 ] - Market Wire
Rotech Healthcare Inc. Announces Proposed Private .. Offering of $290 Million Senior Second Lien Notes
[ Mon, Mar 07th 2011 ] - Market Wire
Compugen Announces Positive Animal Model Results .. de Predicted to Block Protein-Protein Interaction
[ Mon, Mar 07th 2011 ] - Market Wire
ZIOPHARM and Solasia Pharma Announce License and Collaboration Agreement for Darinaparsin in Asia
Sat, March 5, 2011
[ Sat, Mar 05th 2011 ] - Market Wire
Harper Creek Drill Hole HC10-82 Confirms Minerali .. thern Limit of Drill Holes in 2010 Resource Model
Fri, March 4, 2011
[ Fri, Mar 04th 2011 ] - Market Wire
Teva to Present at the Cowen and Company 31st Annual Health Care Conference
[ Fri, Mar 04th 2011 ] - Market Wire
DaVita Is Recognized for Clinical and Operational Excellence Early in 2011
[ Fri, Mar 04th 2011 ] - Market Wire
CPEX Receives Letter from Athyrium Capital Management
[ Fri, Mar 04th 2011 ] - Market Wire
Court Ruling Clears Way for Jury Trial in $1 Billion Texas Medicaid Whistleblower Lawsuit
[ Fri, Mar 04th 2011 ] - Market Wire
Prana's Co-Founding Scientist Awarded Prestigious Australia Fellowship
[ Fri, Mar 04th 2011 ] - Market Wire
Medtronic Announces European Launch of Achievea" Mapping Catheter
[ Fri, Mar 04th 2011 ] - Market Wire
PacificHealth Laboratories Reports 2010 Financial Results
[ Fri, Mar 04th 2011 ] - Market Wire
Amyris entra em acordo para a fabricao do Biofenea" com a Antibiticos, S.A.
[ Fri, Mar 04th 2011 ] - Market Wire
Amyris to Webcast Management Presentation
[ Fri, Mar 04th 2011 ] - Market Wire
Aoxing Pharmaceutical Company to Present at Rodman & Renshaw Annual China Investment Conference
[ Fri, Mar 04th 2011 ] - Market Wire
Drug Approval Process May Be Faster but It's Also Stricter
[ Fri, Mar 04th 2011 ] - Market Wire
Peregrine to Report Third Quarter Fiscal Year 201 .. cial Results After Market Close on March 11, 2011
[ Fri, Mar 04th 2011 ] - Market Wire
ISTA Pharmaceuticals Files Citizen Petition (CP) With U.S. Food and Drug Administration
[ Fri, Mar 04th 2011 ] - Market Wire
Centric Health Terminates Discussions to Acquire DNPI Group
[ Fri, Mar 04th 2011 ] - Market Wire
Amyris Contracts for Biofenea" Manufacture with Antibiticos, S.A.
Thu, March 3, 2011
[ Thu, Mar 03rd 2011 ] - Market Wire
Northstar Healthcare to announce Q4 and Year End .. results March 9 and hold conference call March 10
[ Thu, Mar 03rd 2011 ] - Market Wire
Exelixis Announces Webcasts of Investor Events in March
[ Thu, Mar 03rd 2011 ] - Market Wire
DURATION-6 Top-Line Study Results Announced
[ Thu, Mar 03rd 2011 ] - Market Wire
Dynavax to Present at the Cowen Healthcare Conference
[ Thu, Mar 03rd 2011 ] - Market Wire
Pharmaceuticals to Experience Wide Changes - In-D .. rch Featuring Novavax and Radient Pharmaceuticals
[ Thu, Mar 03rd 2011 ] - Market Wire
Call Genie Announces Closing of Aggregate $5,000,000 Convertible Debenture Financing
[ Thu, Mar 03rd 2011 ] - Market Wire
Marina Biotech Publishes Pre-Clinical Research on .. ics Targeting Survivin and PLK1 in Bladder Cancer
[ Thu, Mar 03rd 2011 ] - Market Wire
MEDIA ADVISORY - Oncolytics Biotech® Inc. to .. st Annual Cowen and Company Healthcare Conference
[ Thu, Mar 03rd 2011 ] - Market Wire
Radient Pharmaceuticals' Onko-Sure & General Cancer Screening Program in India
[ Thu, Mar 03rd 2011 ] - Market Wire
Inaugural International Colon Capsule Expert Meet .. That Underscore Value of Colon Capsule Endoscopy
[ Thu, Mar 03rd 2011 ] - Market Wire
Insulet Corporation to Present at the Cowen and Company 31st Annual Health Care Conference
[ Thu, Mar 03rd 2011 ] - Market Wire
Cornerstone Therapeutics Reports Fiscal Year 2010 Financial Results
[ Thu, Mar 03rd 2011 ] - Market Wire
Huifeng Bio-Pharmaceutical Technology, Inc. to Pr .. nshaw Annual China Investment Conference in Shang
[ Thu, Mar 03rd 2011 ] - Market Wire
Alnylam to Webcast Presentation at 31st Annual Cowen and Company Health Care Conference
[ Thu, Mar 03rd 2011 ] - Market Wire
Osiris Therapeutics Completes Enrollment of Stem Cell Trial for the Treatment of Heart Attacks
Wed, March 2, 2011
[ Wed, Mar 02nd 2011 ] - Market Wire
The Law Offices of Vincent Wong Announce an Inves .. es of Fiduciary Duty by the Board of Clinical Dat
[ Wed, Mar 02nd 2011 ] - Market Wire
ZIOPHARM to Present at Cowen and Company 31st Annual Health Care Conference
[ Wed, Mar 02nd 2011 ] - Market Wire
MEDNAX to Present at Raymond James 32nd Annual Institutional Investors Conference
[ Wed, Mar 02nd 2011 ] - Market Wire
Hemisphere GPS Announces Closing of Cdn$8 Million Bought Deal Financing
[ Wed, Mar 02nd 2011 ] - Market Wire
Significant Shift on Horizon for Pharmaceuticals .. g RXi Pharmaceuticals and Poniard Pharmaceuticals
[ Wed, Mar 02nd 2011 ] - Market Wire
Healthcare Sector Faces Greater FDA Scrutiny
[ Wed, Mar 02nd 2011 ] - Market Wire
Marina Biotech Announces Significant Knockdown of .. cer Target in a Rodent Model of Malignant Ascites
[ Wed, Mar 02nd 2011 ] - Market Wire
Parkinson's Therapeutics Reviewed by NeuroInvestment
[ Wed, Mar 02nd 2011 ] - Market Wire
ADVISORY - Nordion to Release First Quarter 2011 Financial Results
[ Wed, Mar 02nd 2011 ] - Market Wire
Company Files MelaFind(R) PMA Amendment With U.S. Food and Drug Administration
[ Wed, Mar 02nd 2011 ] - Market Wire
Celsion Receives European Orphan Drug Designation for ThermoDox(R) to Treat Primary Liver Cancer
[ Wed, Mar 02nd 2011 ] - Market Wire
Insulet Corporation and GlaxoSmithKline Inc. Sign .. r the OmniPod Insulin Management System in Canada
[ Wed, Mar 02nd 2011 ] - Market Wire
New Breast Reconstruction Procedure Demonstrates .. Trial; Data Reported From Cytori's RESTORE-2 Stu
[ Wed, Mar 02nd 2011 ] - Market Wire
GTSO Rare Earth JV Closing in on New Mongolian Mining Claims
[ Wed, Mar 02nd 2011 ] - Market Wire
BURCON AMENDS LETTER OF INTENT
Tue, March 1, 2011
[ Tue, Mar 01st 2011 ] - Market Wire
RXi Pharmaceuticals Prices $8.1 Million Public Offering of Common Stock and Warrants
[ Tue, Mar 01st 2011 ] - Market Wire
Cerus to Present at the Cowen and Company 31stAnnual Health Care Conference
[ Tue, Mar 01st 2011 ] - Market Wire
Pfizer Completes Acquisition Of King Pharmaceuticals, Inc.
[ Tue, Mar 01st 2011 ] - Market Wire
Repligen to Present at the Cowen and Company 31st Annual Healthcare Conference
[ Tue, Mar 01st 2011 ] - Market Wire
CIGNA Corporation to Host Investor Day on March 11, 2011
[ Tue, Mar 01st 2011 ] - Market Wire
Celsion to Present at Cowen and Company 31st Annual Health Care Conference
[ Tue, Mar 01st 2011 ] - Market Wire
AVI BioPharma to Present Company Overview at the .. en and Company 31st Annual Health Care Conference
[ Tue, Mar 01st 2011 ] - Market Wire
Celsion Announces ThermoDox(R) Preclinical Data P .. Presentations at Upcoming Scientific Conferences
[ Tue, Mar 01st 2011 ] - Market Wire
Covidien Launches New Global Packaging
[ Tue, Mar 01st 2011 ] - Market Wire
Covidien fhrt weltweit neue Verpackungen ein
[ Tue, Mar 01st 2011 ] - Market Wire
Covidien lance un nouvel emballage la?©chelle mondiale
[ Tue, Mar 01st 2011 ] - Market Wire
Covidien lana nova embalagem global
[ Tue, Mar 01st 2011 ] - Market Wire
Covidien lancia il nuovo packaging mondiale
[ Tue, Mar 01st 2011 ] - Market Wire
Covidien presenta nuevo empaque global
Mon, February 28, 2011
[ Mon, Feb 28th 2011 ] - Market Wire
Somaxon Pharmaceuticals to Present at Upcoming Investor Conferences
[ Mon, Feb 28th 2011 ] - Market Wire
Amyris Reports Fourth Quarter and 2010 Year-End Results
[ Mon, Feb 28th 2011 ] - Market Wire
Ironwood Pharmaceuticals to Host Fourth Quarter 2010 Investor Update Call
[ Mon, Feb 28th 2011 ] - Market Wire
Merck to Present at Citi 2011 Global Health Care Conference
[ Mon, Feb 28th 2011 ] - Market Wire
Aetna, OSS Orthopaedic Hospital Reach Agreement
[ Mon, Feb 28th 2011 ] - Market Wire
Kendall Law Group Investigates Forest Laboratories, Inc. for Shareholders
[ Mon, Feb 28th 2011 ] - Market Wire
Medtronic Mosaic® Heart Valve Demonstrates Long- .. Durability up to 12 Years in International Study
[ Mon, Feb 28th 2011 ] - Market Wire
Inhibitex to Host Conference Call to Report Fourt .. Year-End 2010 Financial Results on March 11, 2011
[ Mon, Feb 28th 2011 ] - Market Wire
GTSO to Coordinate New Rare Earth Exports at Mongolian Embassy in DC this Week
[ Mon, Feb 28th 2011 ] - Market Wire
BIOLASE Announces Successful Showing of Waterlase .. r at 146th Chicago Dental Society Midwinter Meeti
[ Mon, Feb 28th 2011 ] - Market Wire
Former-Deputy Surgeon General Canada Appointed President of Medizone International
[ Mon, Feb 28th 2011 ] - Market Wire
Amyris Sells First Renewable Product
[ Mon, Feb 28th 2011 ] - Market Wire
Amyris comercializa seu primeiro produto renovvel
[ Mon, Feb 28th 2011 ] - Market Wire
Thermo Fisher Scientific Announces Redemption of .. 5% Convertible Senior Subordinated Notes Due 2024

Synergy Pharmaceuticals to Present at BIO-Europe Spring 2011 Conference


//health-fitness.news-articles.net/content/2011/ .. resent-at-bio-europe-spring-2011-conference.html
Published in Health and Fitness on Tuesday, March 8th 2011 at 10:50 GMT by Market Wire   Print publication without navigation


NEW YORK--([ BUSINESS WIRE ])--Synergy Pharmaceuticals, Inc. (OTCBB: SGYP), a developer of new drugs to treat gastrointestinal (GI) disorders and diseases, today announced that Dr. Gary S. Jacob, the company's president and chief executive officer, is scheduled to present at BIO-Europe Spring 2011 Conference in Milan, Italy on March 14-16. Dr. Jacoba™s presentation will be given at the Milano Convention Centre, Level 1, Room yellow 3 at 11:00 am CET on March 15, 2011.

About Synergy Pharmaceuticals, Inc.

Synergy is a biopharmaceutical company focused on the development of new drugs to treat gastrointestinal disorders and diseases. Synergy's proprietary drug candidate plecanatide is a synthetic analog of the human gastrointestinal hormone uroguanylin, and functions by activating the guanylate cyclase C (GC-C) receptor on epithelial cells of the GI tract. Plecanatide has recently completed a Phase IIa clinical trial in patients to treat CC. The Company plans to initiate a Phase II/III 90-day repeated-oral-dose, placebo-controlled clinical trial of plecanatide in CC patients in the second half of 2011. Plecanatide is also being developed to treat IBS-C, with the first trial in IBS-C patients planned for 2012. More information is available at [ http://www.synergypharma.com ].


Publication Contributing Sources